
Styla Pharmaceutical Private Limited
Pharmaceutical company that produces and distributes various medical products.
Pharmaceutical company that produces and distributes various medical products.
Styla Pharmaceutical Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 November 2020 (Four years and five months 2 days old ). Its registered office is in Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Sukhwinder Kaur, Paraspreet Singh, and Gaurav Sardana serve as directors at the Company.
Chandigarh, India
+91-XXXXXXXXXX
U24230CH2020PTC043353
043353
Private Limited Indian Non-Government Company
24 Nov 2020
30 Sep 2024
31 Mar 2024
Unlisted
Roc Chandigarh
Styla Pharmaceutical Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Pain Relief Drugs & Pharmaceuticals, Antipyretic Medication, Diclofenac, Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder, Health Supplement, Vitamin Tablets & Capsules, Muscle Relaxant.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sukhwinder Kaur ![]() | Director | 24-Nov-2020 | Current |
Paraspreet Singh ![]() | Director | 18-May-2023 | Current |
Gaurav Sardana | Director | 11-Nov-2024 | Current |
Styla Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 47047.83% increase. The company also saw a substantial fall in profitability, with a 527.85% decrease in profit. The company's net worth observed a substantial decline by a decrease of 49.33%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
Unlock access to Styla Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
There are no open charges registered against the company as per our records.
Styla Pharmaceutical has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Styla Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Styla Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Gaurav Sardana was appointed as a Director was appointed as a Director on 11 Nov 2024 & has been associated with this company since 5 months 15 days .
Styla Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Styla Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh.
Paraspreet Singh was appointed as a Director was appointed as a Director on 18 May 2023 & has been associated with this company since 1 year 11 months .
Sukhwinder Kaur was appointed as a Director was appointed as a Director on 24 Nov 2020 & has been associated with this company since 4 years 5 months .
Styla Pharmaceutical Private Limited was registered on 24 Nov 2020 with Roc Chandigarh & aged 4 years 5 months as per MCA records.
Styla Pharmaceutical Private Limited was incorporated on 24 Nov 2020.
The authorized share capital of Styla Pharmaceutical Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.20 M.
Currently 3 directors are associated with Styla Pharmaceutical Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Styla Pharmaceutical Private Limited is Shop No. 460 Ground Floor Dera Sahib Mohalla Samadhi Gate, Manimajra India, Chandigarh, 160101.
The corporate identification number (CIN) of Styla Pharmaceutical Private Limited is U24230CH2020PTC043353 and the company number is 043353 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Styla Pharmaceutical Private Limited has risen by 47047.83%.
The financial reports for the fiscal year 2022 indicates that The net worth of Styla Pharmaceutical Private Limited has experienced an downturn of -49.33%.
The most recent Balance Sheet for Styla Pharmaceutical Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
SB